Therapeutic privilege (TP) is a defence that may be available to doctors who fail to disclose to the patient relevant information when seeking informed consent for treatment if they have a reasonable ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Direct-to-consumer (DTC) genetic services have generated enormous controversy from their first emergence. A dramatic recent manifestation of this is the Food and Drug Administration's (FDA) cease and ...
3 School of Communication, Simon Fraser University, Burnaby, British Columbia, Canada Correspondence to Dr Jeremy Snyder, Simon Fraser University, Blusson Hall 10516, 8888 University Drive, Burnaby, ...
In Australia and other countries, certain groups of women have traditionally been denied access to assisted reproductive technologies (ARTs). These typically are single heterosexual women, lesbians, ...
Correspondence to Patrick Sullivan, The Centre For Social Ethics and Policy, School of Law, University of Manchester, Williamson Building, Oxford Road, Manchester, M13 9PL, UK; ...
Department of History and Philosophy of Science, University of Cambridge, Free School Lane, Cambridge CB2 3RH, UK; jm439@cam.ac.uk If you wish to reuse any or all of ...
Until 2008, if doctors followed the General Medical Council's (GMC's) guidance on providing information prior to obtaining a patient's consent to treatment, they would be going beyond what was ...
Correspondence to Professor John McMillan, Bioethics Centre, University of Otago, Dunedin 9054, Otago, New Zealand; john.r.mcmillan68{at}gmail.com One set of worries concerns authorship and whether it ...
Objectives Medical futility at the end of life is a growing challenge to medicine. The goals of the authors were to elucidate how clinicians define futility, when they perceive life-sustaining ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results